Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam

Tropical Medicine and International Health

Volumn 19, Issue 9, 2014, Pages 1076-1081

  Hoa, Nguyen B ^a,b   Khanh, Pham H ^c   Chinh, Nguyen V ^a   Hennig, Cornelia M ^c  

^a National Tuberculosis Programme Vietnam   (Viet Nam)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c WHO   (Viet Nam)

Author keywords

Green Light Committee; Multidrug resistant TB; Private sector; Treatment outcome

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

COHORT ANALYSIS; DRUG RESISTANCE; HEALTH RISK; PRIVATE SECTOR; PUBLIC HEALTH; SPATIOTEMPORAL ANALYSIS; TUBERCULOSIS;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; PRESCRIPTION; RETROSPECTIVE STUDY; THERAPY DELAY; TREATMENT OUTCOME; VIET NAM; YOUNG ADULT; DRUG COMBINATION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GAS LIQUID CHROMATOGRAPHY; GREEN LIGHT COMMITTEE; HEALTH CARE DELIVERY; HOSPITAL; MICROBIOLOGY; MULTIDRUG-RESISTANT TB; MYCOBACTERIUM TUBERCULOSIS; ORGANIZATION AND MANAGEMENT; PROGRAM EVALUATION; RESULTADO DEL TRATAMIENTO; RÉSULTATS DU TRAITEMENT; SECTEUR PRIVÉ; SECTOR PRIVADO; TB-MDR; TUBERCULOSE MULTIRÉSISTANTE; TUBERCULOSIS MULTIDROGORESISTENTE;

VIET NAM;

GLC; GREEN LIGHT COMMITTEE; MULTIDRUG-RESISTANT TB; PRIVATE SECTOR; RESULTADO DEL TRATAMIENTO; RÉSULTATS DU TRAITEMENT; SECTEUR PRIVÉ; SECTOR PRIVADO; TB-MDR; TREATMENT OUTCOME; TUBERCULOSE MULTIRÉSISTANTE; TUBERCULOSIS MULTIDROGORESISTENTE;

ADULT; ANTITUBERCULAR AGENTS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIETNAM; YOUNG ADULT;

EID: 84907288889     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12347     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention (CDC) (2012). CDC Role's in global tuberculosis control. Available from: http://www.cdc.gov/tb/topic/globaltb/role.htm (accessed 8 April, 2014).
2. Chan ED, Laurel V, Strand MJ et al. (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine 169, 1103-1109.
3. Chiang CY, Enarson DA, Yu MC et al. (2006) Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study. European Respiratory Journal 28, 980-985.
4. Joseph P, Rao Desai VB, Sunder Mohan N et al. (2011) Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India. Indian Journal of Medical Research 133, 529-534.
5. Leimane V, Riekstina V, Holtz TH et al. (2005) Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 365, 318-326.
6. Malla P, Kanitz EE, Akhtar M et al. (2009) Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006. PLoS One 4, e8313.
7. Marais B, Munez N, Quelapio MI, Hennig C & Khanh P (2012) PMDT Monitoring Mission Report, Viet Nam. 12-16 March 2012. Viet Nam National Tuberculosis Programme, Hanoi, Viet Nam.
8. Tahaoglu K, Törün T, Sevim T et al. (2001) The treatment of multidrug-resistant tuberculosis in Turkey. New England Journal of Medicine 345, 170-174.
9. Viet Nam National Tuberculosis Programme (2009). Guidelines for the Management of Drug-resistant Tuberculosis. Ministry of Health, Hanoi.
10. WHO (2008) Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. Emergency update 2008. (WHO Document WHO/HTM/TB/2008.402) WHO, Geneva, Switzerland.
11. WHO (2012) Global Tuberculosis Report 2012. (WHO Document WHO/HTM/TB/2012.6) WHO, Geneva, Switzerland.
12. WHO (2013) Global Tuberculosis Report 2013. (WHO Document WHO/HTM/TB/2013.11) WHO, Geneva, Switzerland.
13. Yew WW, Chan CK, Chau CH et al. (2000) Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest 117, 744-751.